Related Experiment Video
Updated: Jun 15, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Contrast medium nephrotoxicity after renal artery and coronary angioplasty
Paolo Marraccini1, Massimiliano Bianchi, Enza Fommei
1CNR Institute of Clinical Physiology of Pisa, Italy. paolomar@ifc.cnr.it
Insights
Patients undergoing renal angioplasty (PTRA) show less susceptibility to kidney damage from contrast media (CM) compared to those receiving percutaneous coronary intervention (PCI). PTRA
Area of Science:
- Nephrology
- Interventional Cardiology
- Radiology
Background:
- Contrast media (CM) administration can cause renal dysfunction, potentially limiting the benefits of interventional procedures.
- Patients undergoing renal angioplasty (PTRA) are at risk for contrast-induced nephropathy.
- Comparing CM nephrotoxicity in PTRA versus percutaneous coronary intervention (PCI) is crucial for patient management.
Purpose of the Study:
- To compare the susceptibility to the nephrotoxic effects of CM in patients undergoing PTRA versus PCI.
- To assess the impact of CM on renal function in different interventional procedures.
Main Methods:
- A comparative study involving 33 patients undergoing PTRA and 33 patients undergoing PCI.
- Patients were matched for baseline creatinine, gender, and age.
- Postprocedural serum creatinine levels were measured 48 hours after the intervention.
Main Results:
- Serum creatinine nonsignificantly decreased in the PTRA group but significantly increased in the PCI group.
- Changes in serum creatinine differed significantly between the PTRA and PCI groups.
- The observed differences were not attributable to clinical risk profiles or CM volume.
Conclusions:
- Patients undergoing PTRA demonstrated lower susceptibility to CM-induced renal damage compared to PCI patients.
- CM toxicity appears to have minimal influence on the effectiveness of PTRA concerning renal function.
- This preliminary study suggests a potential protective effect or lower risk in PTRA patients regarding CM nephrotoxicity.
Background:
Renal dysfunction induced by iodinated contrast medium (CM) administration can minimize the benefit of the interventional procedure in patients undergoing renal angioplasty (PTRA).
Purpose:
To compare the susceptibility to nephrotoxic effect of CM in patients undergoing PTRA with that of patients submitted to percutaneous coronary intervention (PCI).
Material And Methods:
A total of 33 patients successfully treated with PTRA (PTRA group, mean age 70+/-12 years, 23 female, basal creatinine 1.46+/-0.79, range 0.7-4.9 mg/dl) were compared with 33 patients undergoing successful PCI (PCI group), matched for basal creatinine (1.44+/-0.6, range 0.7-3.4 mg/dl), gender, and age. In both groups postprocedural (48 h) serum creatinine was measured.
Results:
Postprocedural creatinine level decreased nonsignificantly in the PTRA group (1.46+/-0.8 vs. 1.34+/-0.5 mg/dl, P=NS) and increased significantly in the PCI group (1.44+/-0.6 vs. 1.57+/-0.7 mg/dl, P<0.02). Changes in serum creatinine after intervention (after-before) were significantly different between the PTRA and PCI groups (-0.12+/-0.5 vs. 0.13+/-0.3, P=0.014). This difference was not related to either a different clinical risk profile or to the volume of CM administered.
Conclusion:
In this preliminary study patients submitted to PTRA showed a lower susceptibility to renal damage induced by CM administration than PCI patients. The effectiveness of PTRA on renal function seems to be barely influenced by CM toxicity.
Related Concept Videos
Radiological Investigation I: X-ray and CT
Cardiac Catheterization I: Pre-Procedure Overview
Imaging Studies VII: Vascular Imaging
Imaging Studies for Cardiovascular System V: CT
Imaging Studies III: Computed Tomography
Cardiac Catheterization IV: Nursing Management

